Loading…
The Cigna Group is projected to rise to $354.48 by 2027, a +18% move from its current price of $301.06. CI is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $296.35 | $301.10 | $305.93 | +0.01% |
| Aug 1 | $294.44 | $301.14 | $307.99 | +0.03% |
| Aug 2 | $292.99 | $301.18 | $309.60 | +0.04% |
| Aug 3 | $291.78 | $301.22 | $310.96 | +0.05% |
| Aug 4 | $290.73 | $301.26 | $312.17 | +0.07% |
| Aug 5 | $289.78 | $301.30 | $313.28 | +0.08% |
| Aug 6 | $288.91 | $301.34 | $314.30 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $288.91 | $301.34 | $314.30 | +0.09% |
| Week 2 | $284.18 | $301.62 | $320.12 | +0.18% |
| Week 3 | $280.66 | $301.89 | $324.73 | +0.28% |
| Week 4 | $277.77 | $302.17 | $328.72 | +0.37% |
| Week 5 | $275.27 | $302.45 | $332.31 | +0.46% |
| Week 6 | $273.06 | $302.73 | $335.62 | +0.55% |
| Week 7 | $271.06 | $303.01 | $338.72 | +0.65% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
The Cigna Group is a U.S.-based health care insurer and services provider. It operates through two segments, Evernorth Health Services and Cigna Healthcare, delivering a broad range of health-related services and insurance solutions.
The Evernorth Health Services segment includes pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, offering employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations.
The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges.
The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. It was founded in 1792 and is headquartered in Bloomfield, Connecticut.
The Cigna Group (CI) is a healthcare insurer and services company with a market capitalization of $75.73B and a current price of $286.29. It holds the 213th rank by market cap among listed peers.
The stock’s price outlook is represented in a year-by-year forecast that shows a path of steady to accelerating gains. The 2026 average price is $286.29, with notable upside unfolding through 2030 ($444.13 average) and continuing strongly into 2040 ($1,090.69 average) and 2050 ($2,217.66 average). The accompanying ROI figures indicate rising returns over time, with 55.1% in 2030, 281% in 2040, and 674.6% in 2050.
Sentiment shifts from NEUTRAL in 2026–2028 to BULLISH from 2029 onward.
A major floor 14.3% below — a decisive break under it would weaken the trend.
The nearest floor, 8.4% below — buyers have tended to step in here.
Price is pressing into resistance (1.1% away) — a breakout level to watch.
A major ceiling 6.0% above — clearing it would confirm fresh momentum.
Key CI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $287.32 | Buy | $288.29 | Buy |
| MA 10 | $290.75 | Buy | $288.52 | Buy |
| MA 20 | $287.66 | Buy | $288.14 | Buy |
| MA 50 | $286.59 | Buy | $286.12 | Buy |
| MA 100 | $280.60 | Buy | $283.93 | Buy |
| MA 200 | $280.24 | Buy | $285.18 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.85 | Neutral |
| Stoch RSI (14) | 37.81 | Neutral |
| CCI (20) | 36.74 | Neutral |
| Williams %R (14) | -58.48 | Info |
| MACD (12,26,9) | -0.39 | Sell |
| ROC (12) | 0.45 | Buy |
| Bollinger %B (20,2) | 0.61 | Neutral |
| Stochastic %K (14) | 41.52 | Neutral |
| TRIX (15) | 0.06 | Buy |
| Awesome (5,34) | -0.70 | Sell |
| Ultimate (7,14,28) | 46.32 | Neutral |
| Momentum (10) | -2.44 | Sell |
| Aroon Osc (25) | 32.00 | Buy |
| Hull MA (9) | 286.88 | Buy |
| ADX (14) | 10.63 | Neutral |
| ATR (14) | 4.50 | Info |
The 30-day technical picture is mixed but tilts bullish. RSI14 sits at 50, with the 50-day simple moving average at $286.74 and the 200-day simple moving average at $280.30, signaling a marginally constructive tone near the current price.
Key near-term support is seen at $275.68, with resistance at $304.50. The stock’s 30-day trading range spans from a low of $257.54 to a high of $318.25, indicating a relatively wide but upward-leaning swing over the period.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $258.08 | $301.06 | $378.15 | 0% | Neutral | |
| $290.61 | $354.48 | $451.84 | +18% | Neutral | |
| $291.81 | $362.70 | $475.01 | +20% | Bullish | |
| $320.18 | $404.16 | $540.68 | +34% | Bullish | |
| $367.48 | $470.16 | $640.38 | +56% | Bullish | |
| $427.80 | $554.05 | $766.64 | +84% | Bullish | |
| $483.15 | $632.82 | $888.15 | +110% | Bullish | |
| $499.71 | $661.43 | $940.37 | +120% | Bullish | |
| $525.27 | $702.20 | $1,010.30 | +133% | Bullish | |
| $560.40 | $756.26 | $1,100.23 | +151% | Bullish | |
| $834.16 | $1,174.19 | $1,790.38 | +290% | Bullish | |
| $1,574.69 | $2,377.43 | $3,886.20 | +690% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $258.08 | $301.06 | $351.21 | +0.00% |
| August 2026 | $255.80 | $298.40 | $354.86 | -0.88% |
| September 2026 | $259.74 | $304.70 | $365.67 | +2.11% |
| October 2026 | $261.55 | $308.21 | $372.60 | +1.15% |
| November 2026 | $258.09 | $305.27 | $371.24 | -0.96% |
| December 2026 | $260.58 | $309.28 | $378.15 | +1.31% |
Click any year to see its month-by-month CI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CI is projected to trade between $258.08 and $378.15, averaging $301.06 — a potential gain of 0% from today's $301.06. A consolidation phase looks the most probable path here.
The Cigna Group's 2027 outlook centres on $354.48, within a $290.61 to $451.84 range. That is up +18% on the projected 2026 average. That marks a +18% change versus current levels. Price action looks broadly range-bound.
By 2028, CI could reach as high as $475.01, with a base case around $362.70 and support toward $291.81 — roughly +20% from $301.06. Buyers look set to stay in control over this stretch.
Expect CI to range from $320.18 to $540.68 through 2029. The $404.16 average target implies a +34% move from current prices. That is up +11% on the projected 2028 average. Momentum favours further upside here.
The CI price prediction for 2030 points to an average of $470.16 (low $367.48, high $640.38) — a potential gain of +56% on today's $301.06. Buyers look set to stay in control over this stretch.
In 2031, CI is projected to trade between $427.80 and $766.64, averaging $554.05 — a potential gain of +84% from today's $301.06. That is up +18% on the projected 2030 average. Momentum favours further upside here.
The Cigna Group's 2032 outlook centres on $632.82, within a $483.15 to $888.15 range. That is up +14% on the projected 2031 average. That marks a +110% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CI could reach as high as $940.37, with a base case around $661.43 and support toward $499.71 — roughly +120% from $301.06. Momentum favours further upside here.
Expect CI to range from $525.27 to $1,010.30 through 2034. The $702.20 average target implies a +133% move from current prices. That is up +6% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CI price prediction for 2035 points to an average of $756.26 (low $560.40, high $1,100.23) — a potential gain of +151% on today's $301.06. Momentum favours further upside here.
In 2040, CI is projected to trade between $834.16 and $1,790.38, averaging $1,174.19 — a potential gain of +290% from today's $301.06. That is up +55% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The Cigna Group's 2050 outlook centres on $2,377.43, within a $1,574.69 to $3,886.20 range. That is up +102% on the projected 2040 average. That marks a +690% change versus current levels. Momentum favours further upside here.
Investing $1,000 in CI today (≈ 3.321597 CI) could be worth
$7,896.86
+$6,896.86 (+690%) by 2050 · US Dollar
Based on the average projected CI price of $2,377.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CIwould be worth at today's price.
$1,000 invested in CI on Jul 28, 2025 (≈ 3.420089 CI) would be worth
$1,029.65
+$29.65 (+3.0%) today · 1.03× · US Dollar
Based on a CI entry price of $292.39 vs. today's $301.06.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $283.94 | $1,060.29 | +6.0% |
| 1 month ago | $282.79 | $1,064.61 | +6.5% |
| 3 months ago | $284.92 | $1,056.65 | +5.7% |
| 6 months ago | $272.38 | $1,105.29 | +10.5% |
| 1 year ago | $292.39 | $1,029.65 | +3.0% |
| All time (5.0y) ago | $229.35 | $1,312.67 | +31.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CI forecast.
Our base-case forecast reaches $600.00 around 2032.
Implied market cap at $600.00: $158.72B
The multi-year forecast shows a pronounced longer-term uptrend. In 2030, the average price is projected at $444.13 with a 55.1% ROI, and sentiment is BULLISH. By 2040, the average rises to $1,090.69 with a 281% ROI, remaining BULLISH as the price path extends higher. By 2050, the average is $2,217.66 with a 674.6% ROI, continuing the bullish trajectory.
Max price projections also illustrate substantial upside: $605.06 in 2030, $1,663.24 in 2040, and $3,625.34 in 2050. The forecast escalates from NEUTRAL in 2026–2028 to BULLISH from 2029 onward, reflecting an expanding profitability backdrop and higher price expectations, though these figures are estimates, not guarantees.
Tap a question to reveal the answer.
2030 forecast: avg $444.13, min $347.07, max $605.06; ROI 55.1%; sentiment BULLISH.
Forecasts show a shift to BULLISH from 2029 onward with rising averages: 2030 avg $444.13 (ROI 55.1%), 2040 avg $1,090.69 (ROI 281%), and 2050 avg $2,217.66 (ROI 674.6%). However, these are estimates and not guarantees.
Yes. The 2035 projection shows a max of $1,034.47, indicating that the price could exceed $1,000 within the forecast horizon.
The 30-day range is $257.54 to $318.25.
Current price is $286.29 and market cap is $75.73B.
The Cigna Group Community Discussion
0Share your The Cigna Group price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.